Development
Silo Pharma, Inc.
SILO
$0.5983
-$0.0411-6.43%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -4.24M | -4.57M | -4.21M | -3.91M | -3.33M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 244.80K | 273.00K | 422.70K | 486.20K | 402.00K |
| Change in Net Operating Assets | 797.00K | 741.40K | 386.90K | -75.40K | -453.20K |
| Cash from Operations | -3.20M | -3.55M | -3.40M | -3.50M | -3.39M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -8.58M | -9.83M | -5.94M | 86.70K | 436.20K |
| Cash from Investing | -8.58M | -9.83M | -5.94M | 86.70K | 436.20K |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 0.00 | 4.94M | 4.94M | 4.94M | 4.94M |
| Repurchase of Common Stock | -276.70K | -131.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | 481.90K |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -481.90K |
| Cash from Financing | -276.70K | 4.81M | 4.94M | 4.94M | 4.94M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.05M | -8.58M | -4.40M | 1.53M | 1.99M |